Technology and innovation

Renovis is committed to providing innovative products that help surgeons meet demanding patient needs.  By combining advanced materials and innovative design features with tried-and-true design principals, Renovis aims to enhance device performance and longevity. … [read more]

Tesera SA Stand-Alone ALIF Cage System

Is a porous titanium Stand-alone Anterior Cage designed to be part of the fusion, rather than merely a vessel for it.

Tesera SA Stand-Alone ALIF Cage System Tesera SA Stand-Alone ALIF Cage System

Tesera Trabecular Technology

Designed and built to promote bone in-growth and long-term stability.

Tesera Trabecular Technology Tesera Trabecular Technology

Renovis E-MAX™ Highly Crosslinked Polyethylene

Vitamin E blended for protection against oxidation ...

Renovis E-MAX™ Highly Crosslinked Polyethylene Renovis E-MAX™ Highly Crosslinked Polyethylene

Tesera SC Stand-Alone Cervical Interbody System

Combines advanced material science and revolutionary manufacturing process into a powerful ...

Tesera SC Stand-Alone Cervical Interbody System Tesera SC Stand-Alone Cervical Interbody System
Renovis Hip Product Group Renovis Knee Product Group Renovis Spine Product Group Renovis Trauma Product Group

Distributor Inquiry

Technology Spotlight

Tesera Trabecular Technology information.

Events

NASS 2017 - Booth 1347

North American Spine Society Annual Meeting
October 25 - 28, 2017 – Orlando, Florida

AAHKS 2017 - Booth 302

American Association of Hip and Knee Surgeons Annual Meeting
November 2-5, 2017 – Dallas, Texas

AAOS 2018 - Booth 3875

American Academy of Orthopedic Surgeons Annual Meeting
March 6 - 10, 2018 – New Orleans, Louisiana

AANS 2018 - Booth TBA

American Association of Neurological Surgeons Annual Scientific Meeting
March 6 - 10, 2018 – New Orleans, Louisiana

Press Release

Renovis Surgical Receives FDA Clearance for 3D-printed Posterior Lumbar Interbody Fusion Systems

--- Press Release --- Redlands, CA / Austin, TX (August 9, 2017) – Renovis Surgical Technologies, Inc. announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market posterior lumbar Tesera® porous titanium interbody fusion systems. These systems feature implants for direct posterior (PLIF) … [read more]